171 related articles for article (PubMed ID: 11045871)
1. Molecular basis for treating endometriosis with aromatase inhibitors.
Bulun SE; Zeitoun KM; Takayama K; Sasano H
Hum Reprod Update; 2000; 6(5):413-8. PubMed ID: 11045871
[TBL] [Abstract][Full Text] [Related]
2. Estrogen production and metabolism in endometriosis.
Bulun SE; Yang S; Fang Z; Gurates B; Tamura M; Sebastian S
Ann N Y Acad Sci; 2002 Mar; 955():75-85; discussion 86-8, 396-406. PubMed ID: 11949967
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms of excessive estrogen formation in endometriosis.
Bulun SE; Gurates B; Fang Z; Tamura M; Sebastian S; Zhou J; Amin S; Yang S
J Reprod Immunol; 2002; 55(1-2):21-33. PubMed ID: 12062819
[TBL] [Abstract][Full Text] [Related]
4. Role of aromatase in endometrial disease.
Bulun SE; Yang S; Fang Z; Gurates B; Tamura M; Zhou J; Sebastian S
J Steroid Biochem Mol Biol; 2001 Dec; 79(1-5):19-25. PubMed ID: 11850203
[TBL] [Abstract][Full Text] [Related]
5. Estrogen biosynthesis in endometriosis: molecular basis and clinical relevance.
Bulun SE; Zeitoun KM; Takayama K; Sasano H
J Mol Endocrinol; 2000 Aug; 25(1):35-42. PubMed ID: 10915216
[TBL] [Abstract][Full Text] [Related]
6. Aromatase: a key molecule in the pathophysiology of endometriosis and a therapeutic target.
Zeitoun KM; Bulun SE
Fertil Steril; 1999 Dec; 72(6):961-9. PubMed ID: 10593363
[TBL] [Abstract][Full Text] [Related]
7. Stimulation of aromatase P450 promoter (II) activity in endometriosis and its inhibition in endometrium are regulated by competitive binding of steroidogenic factor-1 and chicken ovalbumin upstream promoter transcription factor to the same cis-acting element.
Zeitoun K; Takayama K; Michael MD; Bulun SE
Mol Endocrinol; 1999 Feb; 13(2):239-53. PubMed ID: 9973254
[TBL] [Abstract][Full Text] [Related]
8. Estrogen production in endometriosis and use of aromatase inhibitors to treat endometriosis.
Bulun SE; Zeitoun K; Takayama K; Noble L; Michael D; Simpson E; Johns A; Putman M; Sasano H
Endocr Relat Cancer; 1999 Jun; 6(2):293-301. PubMed ID: 10731122
[TBL] [Abstract][Full Text] [Related]
9. [Aromatase inhibitors--theoretical concept and present experiences in the treatment of endometriosis].
Ebert AD; Bartley J; David M; Schweppe KW
Zentralbl Gynakol; 2003; 125(7-8):247-51. PubMed ID: 14505258
[TBL] [Abstract][Full Text] [Related]
10. Aromatase and endometriosis.
Bulun SE; Fang Z; Imir G; Gurates B; Tamura M; Yilmaz B; Langoi D; Amin S; Yang S; Deb S
Semin Reprod Med; 2004 Feb; 22(1):45-50. PubMed ID: 15083380
[TBL] [Abstract][Full Text] [Related]
11. Spatially heterogeneous expression of aromatase P450 through promoter II is closely correlated with the level of steroidogenic factor-1 transcript in endometrioma tissues.
Yang HJ; Shozu M; Murakami K; Sumitani H; Segawa T; Kasai T; Inoue M
J Clin Endocrinol Metab; 2002 Aug; 87(8):3745-53. PubMed ID: 12161505
[TBL] [Abstract][Full Text] [Related]
12. Aromatase and other steroidogenic genes in endometriosis: translational aspects.
Attar E; Bulun SE
Hum Reprod Update; 2006; 12(1):49-56. PubMed ID: 16123052
[TBL] [Abstract][Full Text] [Related]
13. Aromatase in endometriosis and uterine leiomyomata.
Bulun SE; Imir G; Utsunomiya H; Thung S; Gurates B; Tamura M; Lin Z
J Steroid Biochem Mol Biol; 2005 May; 95(1-5):57-62. PubMed ID: 16024248
[TBL] [Abstract][Full Text] [Related]
14. Prostaglandin E2 stimulates aromatase expression in endometriosis-derived stromal cells.
Noble LS; Takayama K; Zeitoun KM; Putman JM; Johns DA; Hinshelwood MM; Agarwal VR; Zhao Y; Carr BR; Bulun SE
J Clin Endocrinol Metab; 1997 Feb; 82(2):600-6. PubMed ID: 9024261
[TBL] [Abstract][Full Text] [Related]
15. [Endometriosis and aromatase inhibitor].
Takayama K; Bulun SE
Nihon Rinsho; 2001 Jan; 59 Suppl 1():157-60. PubMed ID: 11235156
[No Abstract] [Full Text] [Related]
16. Aromatase and endometriosis: estrogens play a role.
Ferrero S; Remorgida V; Maganza C; Venturini PL; Salvatore S; Papaleo E; Candiani M; Leone Roberti Maggiore U
Ann N Y Acad Sci; 2014 May; 1317():17-23. PubMed ID: 24738993
[TBL] [Abstract][Full Text] [Related]
17. Transcriptional activation of steroidogenic factor-1 by hypomethylation of the 5' CpG island in endometriosis.
Xue Q; Lin Z; Yin P; Milad MP; Cheng YH; Confino E; Reierstad S; Bulun SE
J Clin Endocrinol Metab; 2007 Aug; 92(8):3261-7. PubMed ID: 17519303
[TBL] [Abstract][Full Text] [Related]
18. Differential expression of steroidogenic factor-1/adrenal 4 binding protein and liver receptor homolog-1 (LRH-1)/fetoprotein transcription factor in the rat testis: LRH-1 as a potential regulator of testicular aromatase expression.
Pezzi V; Sirianni R; Chimento A; Maggiolini M; Bourguiba S; Delalande C; Carreau S; Andò S; Simpson ER; Clyne CD
Endocrinology; 2004 May; 145(5):2186-96. PubMed ID: 14736734
[TBL] [Abstract][Full Text] [Related]
19. C-Jun NH2-Terminal Kinase and p38 Inhibition Suppresses Prostaglandin E2-Stimulated Aromatase and Estrogen Receptor Levels in Human Endometriosis.
Zeng C; Xu JN; Zhou Y; Yang HX; Zhou YF; Xue Q
J Clin Endocrinol Metab; 2015 Nov; 100(11):E1404-14. PubMed ID: 26394174
[TBL] [Abstract][Full Text] [Related]
20. Treatment of severe postmenopausal endometriosis with an aromatase inhibitor.
Takayama K; Zeitoun K; Gunby RT; Sasano H; Carr BR; Bulun SE
Fertil Steril; 1998 Apr; 69(4):709-13. PubMed ID: 9548162
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
